The true incidence of<unk>  is unknown since<unk>  is not a reportable disease in the USA. The annual incidence of allergic bronchopulmonary<unk>  is estimated to be 5 million cases worldwide. In contrast, invasive<unk>  is much less common with an incidence of approximately 1 to 2 cases per 100,000 individuals. There is no gender predilection for the development of<unk> . Individuals of all age groups may be affected with<unk> . Elderly patients with long-standing chronic lung diseases and neonates are more likely to develop<unk> . With the advancement of immunosuppressive therapy and higher rates of transplantation, the incidence and detection of<unk>  is increasing in developed countries.
Aspergillosis epidemiology and demographics
Histoplasmosis epidemiology and demographics
Blastomycosis epidemiology and demographics
Mucormycosis epidemiology and demographics
Coccidioidomycosis epidemiology and demographics
Bronchiolitis epidemiology and demographics
Multi-drug-resistant tuberculosis epidemiology and demographics
Pneumoconiosis epidemiology and demographics